HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of the neurogenic bladder in spina bifida.

Abstract
Renal damage and renal failure are among the most severe complications of spina bifida. Over the past decades, a comprehensive treatment strategy has been applied that results in minimal renal scaring. In addition, the majority of patients can be dry for urine by the time they go to primary school. To obtain such results, it is mandatory to treat detrusor overactivity from birth onward, as upper urinary tract changes predominantly start in the first months of life. This means that new patients with spina bifida should be treated from birth by clean intermittent catheterization and pharmacological suppression of detrusor overactivity. Urinary tract infections, when present, need aggressive treatment, and in many patients, permanent prophylaxis is indicated. Later in life, therapy can be tailored to urodynamic findings. Children with paralyzed pelvic floor and hence urinary incontinence are routinely offered surgery around the age of 5 years to become dry. Rectus abdominis sling suspension of the bladder neck is the first-choice procedure, with good to excellent results in both male and female patients. In children with detrusor hyperactivity, detrusorectomy can be performed as an alternative for ileocystoplasty provided there is adequate bladder capacity. Wheelchair-bound patients can manage their bladder more easily with a continent catheterizable stoma on top of the bladder. This stoma provides them extra privacy and diminishes parental burden. Bowel management is done by retrograde or antegrade enema therapy. Concerning sexuality, special attention is needed to address expectations of adolescent patients. Sensibility of the glans penis can be restored by surgery in the majority of patients.
AuthorsTom P V M de Jong, Rafal Chrzan, Aart J Klijn, Pieter Dik
JournalPediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 23 Issue 6 Pg. 889-96 (Jun 2008) ISSN: 0931-041X [Print] Germany
PMID18350321 (Publication Type: Journal Article, Review)
Chemical References
  • Laxatives
  • Muscarinic Antagonists
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Enema
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Laxatives (therapeutic use)
  • Male
  • Muscarinic Antagonists (therapeutic use)
  • Pelvic Floor (physiopathology)
  • Quality of Life
  • Sexual Dysfunction, Physiological (etiology, therapy)
  • Spinal Dysraphism (complications, physiopathology, therapy)
  • Suburethral Slings
  • Treatment Outcome
  • Urinary Bladder (physiopathology)
  • Urinary Bladder, Neurogenic (etiology, physiopathology, therapy)
  • Urinary Catheterization
  • Urinary Tract Infections (etiology, therapy)
  • Urodynamics
  • Urologic Surgical Procedures (instrumentation)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: